BPG is committed to discovery and dissemination of knowledge
Home / Archive / Volume 22, Issue 3
This Article
Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Checklist of Responsibilities for the Scientific Editor of This Article
Publishing Process of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
  • Total Article Views (16624)
All Articles published online
The chart showing PDF series, WORD series, HTML series.
Item 
Count 
PDF1929
WORD348
HTML12218
 Sum=14495
Publishing Process of This Article
The chart showing Browse series, Download series.
Item 
Count 
Browse901
Download1228
 Sum=2129
Jan 21, 2016 (publication date) through Sep 28, 2023
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Cited by in CrossRef
For: Nitzan O, Elias M, Peretz A, Saliba W. Role of antibiotics for treatment of inflammatory bowel disease. World J Gastroenterol 2016; 22(3): 1078-1087 [PMID: 26811648 DOI: 10.3748/wjg.v22.i3.1078]
URL: https://www.wjgnet.com/1007-9327/full/v22/i3/1078.htm
Number Citing Articles
1
Dinakar Swastha, Nambolan Varsha, Suresh Aravind, Kavassery Balasubramanian Samyuktha, Muruganandam Mohaneswari Yokesh, Akshad Balde, Bakthavatchalam Loganathan Ayilya, Soottawat Benjakul, Se-Kwon Kim, Rasool Abdul Nazeer. Alginate-based drug carrier systems to target inflammatory bowel disease: A review. International Journal of Biological Macromolecules 2023; 244: 125472 doi: 10.1016/j.ijbiomac.2023.125472
2
Cambrian Y. Liu, D. Brent Polk. Microbiomes through the Looking Glass: What Do UC?. Cell Host & Microbe 2018; 24(4): 472 doi: 10.1016/j.chom.2018.09.013
3
Kaitlyn Oliphant, Kyla Cochrane, Kathleen Schroeter, Michelle C. Daigneault, Sandi Yen, Elena F. Verdu, Emma Allen-Vercoe, Pieter C. Dorrestein. Effects of Antibiotic Pretreatment of an Ulcerative Colitis-Derived Fecal Microbial Community on the Integration of Therapeutic Bacteria In Vitro . mSystems 2020; 5(1) doi: 10.1128/mSystems.00404-19
4
Michele D. Mignogna, Stefania Leuci. Contemporary Oral Medicine. 2018; : 1 doi: 10.1007/978-3-319-28100-1_9-1
5
J. Garrido-Mesa, F. Algieri, A. Rodríguez-Nogales, T. Vezza, M.P. Utrilla, F. Garcia, N. Chueca, M.E. Rodríguez-Cabezas, N. Garrido-Mesa, J. Gálvez. Immunomodulatory tetracyclines ameliorate DNBS-colitis: Impact on microRNA expression and microbiota composition. Biochemical Pharmacology 2018; 155: 524 doi: 10.1016/j.bcp.2018.07.044
6
Abdullah Hoter, Hassan Y. Naim. The Functions and Therapeutic Potential of Heat Shock Proteins in Inflammatory Bowel Disease—An Update. International Journal of Molecular Sciences 2019; 20(21): 5331 doi: 10.3390/ijms20215331
7
Bo-Zong Shao, Shu-Ling Wang, Jun Fang, Zhao-Shen Li, Yu Bai, Kai Wu. Alpha7 Nicotinic Acetylcholine Receptor Alleviates Inflammatory Bowel Disease Through Induction of AMPK-mTOR-p70S6K-Mediated Autophagy. Inflammation 2019; 42(5): 1666 doi: 10.1007/s10753-019-01027-9
8
Helioswilton Sales-Campos, Siomar Castro Soares, Carlo José Freire Oliveira. An introduction of the role of probiotics in human infections and autoimmune diseases. Critical Reviews in Microbiology 2019; 45(4): 413 doi: 10.1080/1040841X.2019.1621261
9
Mengfan Li, Lijiao Yang, Chenlu Mu, Yue Sun, Yu Gu, Danfeng Chen, Tianyu Liu, Hailong Cao. Gut microbial metabolome in inflammatory bowel disease: From association to therapeutic perspectives. Computational and Structural Biotechnology Journal 2022; 20: 2402 doi: 10.1016/j.csbj.2022.03.038
10
Runxin Xu, Marie-Christin Weber, Xinkai Hu, Philipp-Alexander Neumann, Nazila Kamaly. Annexin A1 based inflammation resolving mediators and nanomedicines for inflammatory bowel disease therapy. Seminars in Immunology 2022; : 101664 doi: 10.1016/j.smim.2022.101664
11
Yousra M. El-Far, Nehal M. Elsherbiny, Mohamed El-Shafey, Eman Said. The interplay of the inhibitory effect of nifuroxazide on NF-κB/STAT3 signaling attenuates acetic acid-induced ulcerative colitis in rats. Environmental Toxicology and Pharmacology 2020; 79: 103433 doi: 10.1016/j.etap.2020.103433
12
Belgin Dogan, Jing Fu, Shiying Zhang, Ellen J. Scherl, Kenneth W. Simpson. Rifaximin decreases virulence of Crohn’s disease-associated Escherichia coli and epithelial inflammatory responses. The Journal of Antibiotics 2018; 71(5): 485 doi: 10.1038/s41429-017-0022-y
13
Hemanta Koley, Debaki Ranjan Howlader, Ushasi Bhaumik. New Look to Phytomedicine. 2019; : 563 doi: 10.1016/B978-0-12-814619-4.00022-7
14
Shuai Wang, Rene Martins, Megan C. Sullivan, Elliot S. Friedman, Ana M. Misic, Ayah El-Fahmawi, Elaine Cristina Pereira De Martinis, Kevin O’Brien, Ying Chen, Charles Bradley, Grace Zhang, Alexander S. F. Berry, Christopher A. Hunter, Robert N. Baldassano, Mark P. Rondeau, Daniel P. Beiting. Diet-induced remission in chronic enteropathy is associated with altered microbial community structure and synthesis of secondary bile acids. Microbiome 2019; 7(1) doi: 10.1186/s40168-019-0740-4
15
Mélissa Chervy, Nicolas Barnich, Jérémy Denizot. Adherent-Invasive E. coli: Update on the Lifestyle of a Troublemaker in Crohn’s Disease. International Journal of Molecular Sciences 2020; 21(10): 3734 doi: 10.3390/ijms21103734
16
Nikoo Hossein-khannazer, Shukoofeh Torabi, Ramin Hosseinzadeh, Shabnam Shahrokh, Hamid Asadzadeh Aghdaei, Arash Memarnejadian, Nadir Kadri, Massoud Vosough. Novel cell-based therapies in inflammatory bowel diseases: the established concept, promising results. Human Cell 2021; 34(5): 1289 doi: 10.1007/s13577-021-00560-w
17
Jillian S Y Lau, Tony M Korman, Ian Woolley. Life-long antimicrobial therapy: where is the evidence?. Journal of Antimicrobial Chemotherapy 2018; 73(10): 2601 doi: 10.1093/jac/dky174
18
Catherine Colquhoun, Michelle Duncan, George Grant. Inflammatory Bowel Diseases: Host-Microbial-Environmental Interactions in Dysbiosis. Diseases 2020; 8(2): 13 doi: 10.3390/diseases8020013
19
Hyemee Kim, Kimberly A. Krenek, Chuo Fang, Yasushi Minamoto, Melissa E. Markel, Jan S. Suchodolski, Stephen T. Talcott, Susanne U. Mertens-Talcott. Polyphenolic derivatives from mango (Mangifera Indica L.) modulate fecal microbiome, short-chain fatty acids production and the HDAC1/AMPK/LC3 axis in rats with DSS-induced colitis. Journal of Functional Foods 2018; 48: 243 doi: 10.1016/j.jff.2018.07.011
20
Peng Zhang, Hua Jiang. Acetyl‐11‐keto‐β‐boswellic Acid Confers Protection in DSS‐Induced Colitis via the JNK–p38 MAPK and NF‐κB Signaling Pathways. Advanced Biology 2023; 7(6) doi: 10.1002/adbi.202200247
21
Lauren J. Mohan, Jacqueline S. Daly, Barbara M. Ryan, Zebunnissa Ramtoola. The future of nanomedicine in optimising the treatment of inflammatory bowel disease. Scandinavian Journal of Gastroenterology 2019; 54(1): 18 doi: 10.1080/00365521.2018.1563805
22
Ana Paula da Fonseca Machado, Marina Vilar Geraldi, Roberto de Paula do Nascimento, Amanda Maria Tomazini Munhoz Moya, Teresa Vezza, Patricia Diez-Echave, Julio Juan Gálvez, Cinthia Bau Betim Cazarin, Mário Roberto Maróstica Júnior. Polyphenols from food by-products: An alternative or complementary therapy to IBD conventional treatments. Food Research International 2021; 140: 110018 doi: 10.1016/j.foodres.2020.110018
23
Morris Gordon, Vassiliki Sinopoulou, Ciaran Grafton-Clarke, Anthony K Akobeng. Antibiotics for the induction and maintenance of remission in ulcerative colitis. Cochrane Database of Systematic Reviews 2022; 2022(5) doi: 10.1002/14651858.CD013743.pub2
24
Jay Fuerte-Stone, Mark Mimee. Host happy hour: Phage cocktail targets IBD-associated microbes. Cell Host & Microbe 2022; 30(10): 1352 doi: 10.1016/j.chom.2022.09.010
25
Danilo Pagliari, Giovanni Gambassi, Ciriaco A. Piccirillo, Rossella Cianci. The Intricate Link among Gut “Immunological Niche,” Microbiota, and Xenobiotics in Intestinal Pathology. Mediators of Inflammation 2017; 2017: 1 doi: 10.1155/2017/8390595
26
Sofia Moran-Ramos, Blanca E. López-Contreras, Samuel Canizales-Quinteros. Gut Microbiota in Obesity and Metabolic Abnormalities: A Matter of Composition or Functionality?. Archives of Medical Research 2017; 48(8): 735 doi: 10.1016/j.arcmed.2017.11.003
27
Elio Rossi, Gabriella Leccese, Valerio Baldelli, Alessia Bibi, Emanuele Scalone, Carlo Camilloni, Moira Paroni, Paolo Landini. Inactivation of the Pyrimidine Biosynthesis pyrD Gene Negatively Affects Biofilm Formation and Virulence Determinants in the Crohn’s Disease-Associated Adherent Invasive Escherichia coli LF82 Strain. Microorganisms 2022; 10(3): 537 doi: 10.3390/microorganisms10030537
28
Maria Elaine Araruna, Catarina Serafim, Edvaldo Alves Júnior, Clelia Hiruma-Lima, Margareth Diniz, Leônia Batista. Intestinal Anti-Inflammatory Activity of Terpenes in Experimental Models (2010–2020): A Review. Molecules 2020; 25(22): 5430 doi: 10.3390/molecules25225430
29
Thomas X. Lu, Zhong Zheng, Linda Zhang, Hui-Lung Sun, Marc Bissonnette, Haochu Huang, Chuan He. A New Model of Spontaneous Colitis in Mice Induced by Deletion of an RNA m6A Methyltransferase Component METTL14 in T Cells. Cellular and Molecular Gastroenterology and Hepatology 2020; 10(4): 747 doi: 10.1016/j.jcmgh.2020.07.001
30
Amir Barkhodari, Kate E. Lee, Min Shen, Bo Shen, Qingping Yao. Inflammatory bowel disease: focus on enteropathic arthritis and therapy. Rheumatology and Immunology Research 2022; 3(2): 69 doi: 10.2478/rir-2022-0012
31
Wenshuo Chen, Haijin Chen, Shudan Fu, Xiaohua Lin, Zheng Zheng, Jinlong Zhang. Microbiome characterization and re-design by biologic agents for inflammatory bowel disease insights. Bioprocess and Biosystems Engineering 2021; 44(5): 929 doi: 10.1007/s00449-020-02380-y
32
Simon Kusan, Güzin Surat, Matthias Kelm, Friedrich Anger, Mia Kim, Christoph-Thomas Germer, Nicolas Schlegel, Sven Flemming. Microbial Spectrum and Antibiotic Resistance in Patients Suffering from Penetrating Crohn’s Disease. Journal of Clinical Medicine 2022; 11(15): 4343 doi: 10.3390/jcm11154343
33
Banafsheh Nadalian, Bahareh Nadalian, Hamidreza Houri, Shabnam Shahrokh, Mohammad Abdehagh, Abbas Yadegar, Gholamhossein Ebrahimipour. Phylogrouping and characterization of Escherichia coli isolated from colonic biopsies and fecal samples of patients with flare of inflammatory bowel disease in Iran. Frontiers in Medicine 2022; 9 doi: 10.3389/fmed.2022.985300
34
Aline C. Fenneman, Melissa Weidner, Lea Ann Chen, Max Nieuwdorp, Martin J. Blaser. Antibiotics in the pathogenesis of diabetes and inflammatory diseases of the gastrointestinal tract. Nature Reviews Gastroenterology & Hepatology 2023; 20(2): 81 doi: 10.1038/s41575-022-00685-9
35
Emanuele Sinagra, Erika Utzeri, Gaetano Cristian Morreale, Carlo Fabbri, Fabio Pace, Andrea Anderloni. Microbiota-gut-brain axis and its affect inflammatory bowel disease: Pathophysiological concepts and insights for clinicians. World Journal of Clinical Cases 2020; 8(6): 1013-1025 doi: 10.12998/wjcc.v8.i6.1013
36
Nicolas Benech, Harry Sokol. Targeting the gut microbiota in inflammatory bowel diseases: where are we?. Current Opinion in Microbiology 2023; 74: 102319 doi: 10.1016/j.mib.2023.102319
37
Gabriela Seydlová, Radek Pohl, Eva Zborníková, Marcel Ehn, Ondřej Šimák, Natalya Panova, Milan Kolář, Kateřina Bogdanová, Renata Večeřová, Radovan Fišer, Hana Šanderová, Dragana Vítovská, Petra Sudzinová, Jiří Pospíšil, Oldřich Benada, Tomáš Křížek, David Sedlák, Petr Bartůněk, Libor Krásný, Dominik Rejman. Lipophosphonoxins II: Design, Synthesis, and Properties of Novel Broad Spectrum Antibacterial Agents. Journal of Medicinal Chemistry 2017; 60(14): 6098 doi: 10.1021/acs.jmedchem.7b00355
38
Xiujing Zhang, Lizhuan Ma, Chao Zhang, Bingxu Hou, Yanli Zhou, Simiao Yu. Silencing LncRNA-DANCR attenuates inflammation and DSS-induced endothelial injury through miR-125b-5p. Gastroenterología y Hepatología 2021; 44(9): 644 doi: 10.1016/j.gastrohep.2020.10.008
39
Xiufang Cui, Haiyang Wang, Ziping Ye, Yi Li, Xinyun Qiu, Hongjie Zhang. Fecal microbiota profiling in irritable bowel syndrome and inflammatory bowel disease patients with irritable bowel syndrome-type symptoms. BMC Gastroenterology 2021; 21(1) doi: 10.1186/s12876-021-02015-w
40
Wimonrat Panpetch, Pornpimol Phuengmaung, Pratsanee Hiengrach, Jiraphorn Issara-Amphorn, Thanya Cheibchalard, Naraporn Somboonna, Somying Tumwasorn, Asada Leelahavanichkul. Candida Worsens Klebsiella pneumoniae Induced-Sepsis in a Mouse Model with Low Dose Dextran Sulfate Solution through Gut Dysbiosis and Enhanced Inflammation. International Journal of Molecular Sciences 2022; 23(13): 7050 doi: 10.3390/ijms23137050
41
Andreas Munk Petersen. Gastrointestinal dysbiosis and Escherichia coli pathobionts in inflammatory bowel diseases. APMIS 2022; 130(S144): 1 doi: 10.1111/apm.13256
42
Lauren Sahakian, Rhiannon T Filippone, Rhian Stavely, Ainsley M Robinson, Xu Sean Yan, Raquel Abalo, Rajaraman Eri, Joel C Bornstein, Mark R Kelley, Kulmira Nurgali. Inhibition of APE1/Ref-1 Redox Signaling Alleviates Intestinal Dysfunction and Damage to Myenteric Neurons in a Mouse Model of Spontaneous Chronic Colitis. Inflammatory Bowel Diseases 2021; 27(3): 388 doi: 10.1093/ibd/izaa161
43
Jongwook Yu, Jae Hee Cheon. Microbial Modulation in Inflammatory Bowel Diseases. Immune Network 2022; 22(6) doi: 10.4110/in.2022.22.e44
44
Subrata Sabui, Jonathan Skupsky, Rubina Kapadia, Kyle Cogburn, Nils W. Lambrecht, Anshu Agrawal, Hamid M. Said. Tamoxifen-induced, intestinal-specific deletion of Slc5a6 in adult mice leads to spontaneous inflammation: involvement of NF-κB, NLRP3, and gut microbiota. American Journal of Physiology-Gastrointestinal and Liver Physiology 2019; 317(4): G518 doi: 10.1152/ajpgi.00172.2019
45
Megan T. Zangara, Lena Darwish, Brian K. Coombes, Alfredo G. Torres. Characterizing the Pathogenic Potential of Crohn’s Disease-Associated Adherent-Invasive Escherichia coli. EcoSal Plus 2023;  doi: 10.1128/ecosalplus.esp-0018-2022
46
Hicheme Hadji, Kawthar Bouchemal. Advances in the treatment of inflammatory bowel disease: Focus on polysaccharide nanoparticulate drug delivery systems. Advanced Drug Delivery Reviews 2022; 181: 114101 doi: 10.1016/j.addr.2021.114101
47
ManishaS Lalan, PranavJ Shah, Ruchita Kadam, HimanP Patel. Amalgam of ternary solid dispersion and P-gp efflux inhibition in development of colon-targeted tablets of rifaximin. Journal of Reports in Pharmaceutical Sciences 2022; 11(2): 222 doi: 10.4103/jrptps.JRPTPS_21_22
48
Weijie Ma, Zimu Gong, Hamzah Abu-Sbeih, Yuanzun Peng, Frederick Peng, Fangwen Zou, Aline Charabaty, Pablo C. Okhuysen, Jennifer L. McQuade, Mehmet Altan, Hao Chi Zhang, Anusha S. Thomas, Yinghong Wang. Outcomes of Immune Checkpoint Inhibitor–related Diarrhea or Colitis in Cancer Patients With Superimposed Gastrointestinal Infections. American Journal of Clinical Oncology 2021; 44(8): 402 doi: 10.1097/COC.0000000000000841
49
Stefan Satka, Veronika Frybortova, Iveta Zapletalova, Pavel Anzenbacher, Eva Anzenbacherova, Hana Kozakova, Dagmar Srutkova, Tomas Hudcovic, Lenka Jourova. Effect of DSS-Induced Ulcerative Colitis and Butyrate on the Cytochrome P450 2A5: Contribution of the Microbiome. International Journal of Molecular Sciences 2022; 23(19): 11627 doi: 10.3390/ijms231911627
50
Zhen-Huan Yang, Fang Liu, Xiao-Ran Zhu, Fei-Ya Suo, Zi-jun Jia, Shu-Kun Yao. Altered profiles of fecal bile acids correlate with gut microbiota and inflammatory responses in patients with ulcerative colitis. World Journal of Gastroenterology 2021; 27(24): 3609-3629 doi: 10.3748/wjg.v27.i24.3609
51
Albert E. Jergens, Shadi Parvinroo, Jamie Kopper, Michael J. Wannemuehler. Rules of Engagement: Epithelial-Microbe Interactions and Inflammatory Bowel Disease. Frontiers in Medicine 2021; 8 doi: 10.3389/fmed.2021.669913
52
Priscila R. Guerra, Fatemeh Ajalloueian, Shaodong Wei, Katja Ann Kristensen, Martin Iain Bahl, Anja Boisen, Tine Rask Licht. Delivery of streptomycin to the rat colon by use of electrospun nanofibers. Scientific Reports 2022; 12(1) doi: 10.1038/s41598-022-25769-z
53
Anum Khan, Amna Bibi, Huma Ali, Asim ur Rehman, Maimoona Qindeel, Muhammad Irfan, Aamer Ali Shah, Malik Badshah, Fariha Hasan, Samiullah Khan. Development of Resistant Starch Film Coated Microparticles for an Oral Colon‐Specific Drug Delivery. Starch - Stärke 2020; 72(7-8) doi: 10.1002/star.201900262
54
Shangqing Zhang, Yan Chi, Hongfang Jin, Xiuli Wang, Xue Zhao, Ying Gao, Junqing Zhang, Liaqat Ali. Alteration of Intestinal Microbiota and Hydrogen Sulfide Metabolism in Patients with Hashimoto’s Thyroiditis. Journal of Healthcare Engineering 2023; 2023: 1 doi: 10.1155/2023/9302189
55
Mohammad Mukim, Mohit Chaturvedi, Rakesh Patel, Supriya Roy, Pratishtha Sharma, Varunesh Chaturvedi, Saloni Goyal, Mohsina F. Patewkar. CROHN’S DISEASE: A REVIEW ON EPIDEMIOLOGY, DIAGNOSIS AND THERAPEUTIC MANAGEMENT. Indian Drugs 2022; 59(09): 16 doi: 10.53879/id.59.09.12577
56
Morris Gordon, Ciaran Grafton-Clarke, Vassiliki Sinopoulou, Anthony K Akobeng. Antibiotics for the induction and maintenance of remission in ulcerative colitis. Cochrane Database of Systematic Reviews 2020;  doi: 10.1002/14651858.CD013743
57
Huimin Jin, Siyan Che, Kunfu Wu, Miaomiao Wu. Ellagic acid prevents gut damage via ameliorating microbe-associated intestinal lymphocyte imbalance. Food & Function 2022; 13(19): 9822 doi: 10.1039/D2FO01512A
58
Xiao-Bo Feng, Jun Jiang, Min Li, Gang Wang, Jin-Wei You, Jian Zuo. Role of intestinal flora imbalance in pathogenesis of pouchitis. Asian Pacific Journal of Tropical Medicine 2016; 9(8): 786 doi: 10.1016/j.apjtm.2016.06.003
59
Shouzhi Zhou, Zhao Yang, Jiaxin Liu, Maojuan Ran. TIPE-2 ameliorates inflammatory bowel disease in mice via inhibiting STAT3 and NF-kB activation. Immunology Letters 2023; 255: 32 doi: 10.1016/j.imlet.2023.02.005
60
Kaori Yoshida, Masanori A. Murayama, Kenji Shimizu, Ce Tang, Nanako Katagiri, Kenzo Matsuo, Fumio Fukai, Yoichiro Iwakura. IL-1R2 deficiency suppresses dextran sodium sulfate-induced colitis in mice via regulation of microbiota. Biochemical and Biophysical Research Communications 2018; 496(3): 934 doi: 10.1016/j.bbrc.2018.01.116
61
Hee Seo, Hyunbin Seong, Ga Yun Kim, Yu Mi Jo, Seong Won Cheon, Youngju Song, Byung Hee Ryu, Hee Kang, Nam Soo Han. Development of Anti-inflammatory Probiotic Limosilactobacillus reuteri EFEL6901 as Kimchi Starter: in vitro and In vivo Evidence. Frontiers in Microbiology 2021; 12 doi: 10.3389/fmicb.2021.760476
62
Catalina Grez, Juan Cristóbal Ossa. ENFERMEDAD INFLAMATORIA INTESTINAL EN PEDIATRÍA, UNA REVISIÓN. Revista Médica Clínica Las Condes 2019; 30(5): 372 doi: 10.1016/j.rmclc.2019.06.009
63
Andrew Del Colle, Narek Israelyan, Kara Gross Margolis. Novel aspects of enteric serotonergic signaling in health and brain-gut disease. American Journal of Physiology-Gastrointestinal and Liver Physiology 2020; 318(1): G130 doi: 10.1152/ajpgi.00173.2019
64
Vikash G. Lala, Bilal Bobat, Mark Haagensen, Prakash Kathan, Adam Mahomed. Metronidazole-induced encephalopathy. South African Journal of Radiology 2021; 25(1) doi: 10.4102/sajr.v25i1.2016
65
Justin A. Hutcherson, Kathryn M. Sinclair, Benjamin R. Belvin, Qin Gui, Paul S. Hoffman, Janina P. Lewis. Amixicile, a novel strategy for targeting oral anaerobic pathogens. Scientific Reports 2017; 7(1) doi: 10.1038/s41598-017-09616-0
66
Jeannette S. Messer, Eugene B. Chang. Physiology of the Gastrointestinal Tract. 2018; : 795 doi: 10.1016/B978-0-12-809954-4.00036-0
67
Radhika Gudi, Jada Suber, Robert Brown, Benjamin M Johnson, Chenthamarakshan Vasu. Pretreatment with Yeast-Derived Complex Dietary Polysaccharides Suppresses Gut Inflammation, Alters the Microbiota Composition, and Increases Immune Regulatory Short-Chain Fatty Acid Production in C57BL/6 Mice. The Journal of Nutrition 2020; 150(5): 1291 doi: 10.1093/jn/nxz328
68
Sarah El-Nakeep. Frontiers of COVID-19. 2022; : 291 doi: 10.1007/978-3-031-08045-6_14
69
Natália Oliveira e Silva, Breno Bittencourt de Brito, Filipe Antônio França da Silva, Maria Luísa Cordeiro Santos, Fabrício Freire de Melo. Probiotics in inflammatory bowel disease: Does it work?. World Journal of Meta-Analysis 2020; 8(2): 54-66 doi: 10.13105/wjma.v8.i2.54
70
Ioanna Aggeletopoulou, Christos Konstantakis, Stelios F. Assimakopoulos, Christos Triantos. The role of the gut microbiota in the treatment of inflammatory bowel diseases. Microbial Pathogenesis 2019; 137: 103774 doi: 10.1016/j.micpath.2019.103774
71
Lama Izzat Hasan Abdel-Rahman, Xochitl C Morgan. Searching for a Consensus Among Inflammatory Bowel Disease Studies: A Systematic Meta-Analysis. Inflammatory Bowel Diseases 2023; 29(1): 125 doi: 10.1093/ibd/izac194
72
Francesco Strati, Georgia Lattanzi, Chiara Amoroso, Federica Facciotti. Microbiota-targeted therapies in inflammation resolution. Seminars in Immunology 2022; 59: 101599 doi: 10.1016/j.smim.2022.101599
73
Adeline Sivignon, Julie Bouckaert, Julien Bernard, Sebastien G. Gouin, Nicolas Barnich. The potential of FimH as a novel therapeutic target for the treatment of Crohn’s disease. Expert Opinion on Therapeutic Targets 2017; 21(9): 837 doi: 10.1080/14728222.2017.1363184
74
Loren Galler Rabinowitz, Stephanie Lauren Gold, Elana A. Maser. Management of Inpatient Inflammatory Bowel Disease. 2022; : 31 doi: 10.1007/978-1-0716-1987-2_3
75
Ying-Kai Hung, Shang-Tse Ho, Ching-Yun Kuo, Ming-Ju Chen. Multiomics Strategy Reveals the Mechanism of Action and Ameliorating Effect of Deer Velvet Antler Water Extracts on DSS-Induced Colitis. Biomedicines 2023; 11(7): 1913 doi: 10.3390/biomedicines11071913
76
Kelly A. Hu, John Gubatan. Gut microbiome–based therapeutics in inflammatory bowel disease. Clinical and Translational Discovery 2023; 3(2) doi: 10.1002/ctd2.182
77
Carolina Palmela, Caroline Chevarin, Zhilu Xu, Joana Torres, Gwladys Sevrin, Robert Hirten, Nicolas Barnich, Siew C Ng, Jean-Frederic Colombel. Adherent-invasive Escherichia coli in inflammatory bowel disease. Gut 2018; 67(3): 574 doi: 10.1136/gutjnl-2017-314903
78
Sulejman Alihodžić, Mirjana Bukvić, Ivaylo J. Elenkov, Antun Hutinec, Sanja Koštrun, Dijana Pešić, Gordon Saxty, Linda Tomašković, Dinko Žiher. . Progress in Medicinal Chemistry 2018; 57: 113 doi: 10.1016/bs.pmch.2018.01.002
79
Wayne Young, Traci Jester, Matthew L. Stoll, Ana Izcue. The Microbiome in Rheumatic Diseases and Infection. 2018; : 251 doi: 10.1007/978-3-319-79026-8_19
80
Sreedhar Subramanian, Anders Ekbom, Jonathan M Rhodes. Recent advances in clinical practice: a systematic review of isolated colonic Crohn's disease: the third IBD?. Gut 2017; 66(2): 362 doi: 10.1136/gutjnl-2016-312673
81
Wei Niu, Fuyan Yang, Ziwei Fu, Yuelin Dong, Zhenhai Zhang, Jianming Ju. The role of enteric dysbacteriosis and modulation of gut microbiota in the treatment of inflammatory bowel disease. Microbial Pathogenesis 2022; 165: 105381 doi: 10.1016/j.micpath.2021.105381
82
Tiziana LARUSSA, Ludovico ABENAVOLI, Giulia FABIANO, Maria A. MANCUSO, Natale POLIMENI, Dan L. DUMITRASCU, Francesco LUZZA. Gut microbiota in inflammatory bowel disease: a target for therapy not to be missed. Minerva Gastroenterology 2022; 67(4) doi: 10.23736/S2724-5985.21.02907-7
83
Federica Facciotti. Modulation of intestinal immune cell responses by eubiotic or dysbiotic microbiota in inflammatory bowel diseases. PharmaNutrition 2022; 21: 100303 doi: 10.1016/j.phanu.2022.100303
84
Yoshiyuki Mishima, Ryan Balfour Sartor. Manipulating resident microbiota to enhance regulatory immune function to treat inflammatory bowel diseases. Journal of Gastroenterology 2020; 55(1): 4 doi: 10.1007/s00535-019-01618-1
85
Joana Costa Antunes, Catarina Leal Seabra, Joana Margarida Domingues, Marta Oliveira Teixeira, Cláudia Nunes, Sofia Antunes Costa-Lima, Natália Cândido Homem, Salette Reis, Maria Teresa Pessoa Amorim, Helena Prado Felgueiras. Drug Targeting of Inflammatory Bowel Diseases by Biomolecules. Nanomaterials 2021; 11(8): 2035 doi: 10.3390/nano11082035
86
Ming Zhang, Kaiji Sun, Yujun Wu, Ying Yang, Patrick Tso, Zhenlong Wu. Interactions between Intestinal Microbiota and Host Immune Response in Inflammatory Bowel Disease. Frontiers in Immunology 2017; 8 doi: 10.3389/fimmu.2017.00942
87
Chiara Amoroso, Federica Perillo, Francesco Strati, Massimo Fantini, Flavio Caprioli, Federica Facciotti. The Role of Gut Microbiota Biomodulators on Mucosal Immunity and Intestinal Inflammation. Cells 2020; 9(5): 1234 doi: 10.3390/cells9051234
88
Áine Abautret-Daly, Elaine Dempsey, Adolfo Parra-Blanco, Carlos Medina, Andrew Harkin. Gut–brain actions underlying comorbid anxiety and depression associated with inflammatory bowel disease. Acta Neuropsychiatrica 2018; 30(5): 275 doi: 10.1017/neu.2017.3
89
Glenn T. Ault, Jennifer S. Beaty. The ASCRS Textbook of Colon and Rectal Surgery. 2022; : 29 doi: 10.1007/978-3-030-66049-9_2
90
John Kuckelman, Eric K. Johnson. Clinical Algorithms in General Surgery. 2019; : 283 doi: 10.1007/978-3-319-98497-1_70
91
Wael Elhenawy, Sarah Hordienko, Steven Gould, Alexander M. Oberc, Caressa N. Tsai, Troy P. Hubbard, Matthew K. Waldor, Brian K. Coombes. High-throughput fitness screening and transcriptomics identify a role for a type IV secretion system in the pathogenesis of Crohn’s disease-associated Escherichia coli. Nature Communications 2021; 12(1) doi: 10.1038/s41467-021-22306-w
92
Filip Ambrozkiewicz, Jakub Karczmarski, Maria Kulecka, Agnieszka Paziewska, Magdalena Niemira, Natalia Zeber-Lubecka, Edyta Zagorowicz, Adam Kretowski, Jerzy Ostrowski. In search for interplay between stool microRNAs, microbiota and short chain fatty acids in Crohn’s disease - a preliminary study. BMC Gastroenterology 2020; 20(1) doi: 10.1186/s12876-020-01444-3
93
Alexander Rodriguez-Palacios, Abigail Raffner Basson, Fabio Cominelli. Artificial Sweeteners and Whole-Food Science: Could Mice Help Clinicians Make Diet Recommendations for IBD Patients?. Gastroenterology 2021; 161(1): 8 doi: 10.1053/j.gastro.2021.03.041
94
Damjana Bogatic, Robert V. Bryant, Kate D. Lynch, Samuel P. Costello. Systematic review: microbial manipulation as therapy for primary sclerosing cholangitis. Alimentary Pharmacology & Therapeutics 2023; 57(1): 23 doi: 10.1111/apt.17251
95
Stephanie N. Spohn, Vincent B. Young. Physiology of the Gastrointestinal Tract. 2018; : 737 doi: 10.1016/B978-0-12-809954-4.00032-3
96
Yu-Chen Lee, Chih-Yi Liu, Chia-Long Lee, Ruo-Han Zhang, Chi-Jung Huang, Ting-Lin Yen. The Periodontopathic Pathogen, Porphyromonas gingivalis, Involves a Gut Inflammatory Response and Exacerbates Inflammatory Bowel Disease. Pathogens 2022; 11(1): 84 doi: 10.3390/pathogens11010084
97
Oumaira Rahmouni, Laurent Dubuquoy, Pierre Desreumaux, Christel Neut. Microbiote intestinal et développement des maladies inflammatoires chroniques de l’intestin. médecine/sciences 2016; 32(11): 968 doi: 10.1051/medsci/20163211012
98
Xuhui Tong, Yuanyuan Zheng, Yu Li, Yongjian Xiong, Dapeng Chen. Soluble ligands as drug targets for treatment of inflammatory bowel disease. Pharmacology & Therapeutics 2021; 226: 107859 doi: 10.1016/j.pharmthera.2021.107859
99
Karin Fetter, Markus Weigel, Benjamin Ott, Moritz Fritzenwanker, Sebastian Stricker, Jan de Laffolie, Torsten Hain. The microbiome landscape in pediatric Crohn’s disease and therapeutic implications. Gut Microbes 2023; 15(2) doi: 10.1080/19490976.2023.2247019
100
Klára Szentmihályi, Krisztina Süle, Anna Egresi, Anna Blázovics, Zoltán May. Metronidazole does not show direct antioxidant activity in in vitro global systems. Heliyon 2021; 7(4): e06902 doi: 10.1016/j.heliyon.2021.e06902
101
SeyedAhmad SeyedAlinaghi, Arian Afzalian, Zahra Pashaei, Sanaz Varshochi, Amirali Karimi, Hengameh Mojdeganlou, Paniz Mojdeganlou, Armin Razi, Farzaneh Ghanadinezhad, Alireza Shojaei, Ava Amiri, Mohsen Dashti, Afsaneh Ghasemzadeh, Omid Dadras, Esmaeil Mehraeen, Amir Masoud Afsahi. Retracted: Gut microbiota and COVID‐19: A systematic review. Health Science Reports 2023; 6(2) doi: 10.1002/hsr2.1080
102
Ritwik Patra, Saubhik Mitra, Nabarun Chandra Das, Suprabhat Mukherjee. Prebiotics, Probiotics and Nutraceuticals. 2022; : 133 doi: 10.1007/978-981-16-8990-1_8
103
Weiwei Wang, Zhui Li, Qiqi Han, Yuming Guo, Bo Zhang, Romain D’inca. Dietary live yeast and mannan-oligosaccharide supplementation attenuate intestinal inflammation and barrier dysfunction induced by Escherichia coli in broilers. British Journal of Nutrition 2016; 116(11): 1878 doi: 10.1017/S0007114516004116
104
Alessia Finotti, Jessica Gasparello, Ilaria Lampronti, Lucia Carmela Cosenza, Giovanni Maconi, Vincenzo Matarese, Valentina Gentili, Dario Di Luca, Roberto Gambari, Michele Caselli. PCR detection of segmented filamentous bacteria in the terminal ileum of patients with ulcerative colitis. BMJ Open Gastroenterology 2017; 4(1): e000172 doi: 10.1136/bmjgast-2017-000172
105
Sucheta Mandal, Narayan Chandra Mandal. Recent Advances and Future Perspectives of Microbial Metabolites. 2023; : 81 doi: 10.1016/B978-0-323-90113-0.00005-5
106
Tolulope Joshua Ashaolu, Samuel Fernández-Tomé. Gut mucosal and adipose tissues as health targets of the immunomodulatory mechanisms of probiotics. Trends in Food Science & Technology 2021; 112: 764 doi: 10.1016/j.tifs.2021.04.040
107
Michele D. Mignogna, Stefania Leuci. Contemporary Oral Medicine. 2019; : 67 doi: 10.1007/978-3-319-72303-7_9
108
Ting Cheng, Chen Xu, Jing Shao. Updated immunomodulatory roles of gut flora and microRNAs in inflammatory bowel diseases. Clinical and Experimental Medicine 2022; 23(4): 1015 doi: 10.1007/s10238-022-00935-9
109
Kseniya M. Achasova, Elena N. Kozhevnikova, Mariya A. Borisova, Ekaterina A. Litvinova. Fucose Ameliorates Tritrichomonas sp.-Associated Illness in Antibiotic-Treated Muc2−/− Mice. International Journal of Molecular Sciences 2021; 22(19): 10699 doi: 10.3390/ijms221910699
110
Mahboube Ganji-Arjenaki, Mahmoud Rafieian-Kopaei. Probiotics are a good choice in remission of inflammatory bowel diseases: A meta analysis and systematic review. Journal of Cellular Physiology 2018; 233(3): 2091 doi: 10.1002/jcp.25911
111
Saeideh Momtaz, Mohammad Amir Azimian, Pardis Gharazi, Mustafa Dehnamaki, Zahra Rezaei, Mahban Rahimifard, Maryam Baeeri, Ali Reza Abdollahi, Mohammad Abdollahi, Mohammad Hosein Farzaei, Amir Hossein Abdolghaffari. The Hydro-alcoholic Extract of Achillea wilhelmsii C. Koch Ameliorates Acetic Acid-induced Ulcerative Colitis through TLR-4. Proceedings of the National Academy of Sciences, India Section B: Biological Sciences 2023; 93(1): 127 doi: 10.1007/s40011-022-01404-9
112
Mabel Guzman-Rodriguez, Julie A.K. McDonald, Richard Hyde, Emma Allen-Vercoe, Erika C. Claud, Prameet M. Sheth, Elaine O. Petrof. Using bioreactors to study the effects of drugs on the human microbiota. Methods 2018; 149: 31 doi: 10.1016/j.ymeth.2018.08.003
113
Robel Tadesse, Biniam Ewnte, Kale’ab Tesfaye. Perforated ileum as the initial presentation of Crohn's disease, a case report. International Journal of Surgery Case Reports 2022; 97: 107305 doi: 10.1016/j.ijscr.2022.107305
114
Ahmad Qasem, Abed Elrahman Naser, Saleh A. Naser. The alternate effects of anti-TNFα therapeutics and their role in mycobacterial granulomatous infection in Crohn’s disease. Expert Review of Anti-infective Therapy 2017; 15(7): 637 doi: 10.1080/14787210.2017.1328276
115
Mohammad Al Mijan, Beong Ou Lim. Diets, functional foods, and nutraceuticals as alternative therapies for inflammatory bowel disease: Present status and future trends. World Journal of Gastroenterology 2018; 24(25): 2673-2685 doi: 10.3748/wjg.v24.i25.2673
116
Jing Zhang, Ziquan Liu, Shanjun Song, Junkai Fang, Lei Wang, Lei Zhao, Chenguang Li, Weixia Li, Hyang-Min Byun, Liqiong Guo, Penghui Li. The exposure levels and health risk assessment of antibiotics in urine and its association with platelet mitochondrial DNA methylation in adults from Tianjin, China: A preliminary study. Ecotoxicology and Environmental Safety 2022; 231: 113204 doi: 10.1016/j.ecoenv.2022.113204
117
J.E. Vazquez Bucheli, S.D. Todorov, W.H. Holzapfel. Role of gastrointestinal microbial populations, a terra incognita of the human body in the management of intestinal bowel disease and metabolic disorders. Beneficial Microbes 2022; 13(4): 295 doi: 10.3920/BM2022.0022
118
Boshen Gong, Chuyuan Wang, Fanrui Meng, Haoyu Wang, Bo Song, Yang Yang, Zhongyan Shan. Association Between Gut Microbiota and Autoimmune Thyroid Disease: A Systematic Review and Meta-Analysis. Frontiers in Endocrinology 2021; 12 doi: 10.3389/fendo.2021.774362
119
Ayla Demirtas. The lived experiences of people with inflammatory bowel diseases: A phenomenological hermeneutic study. International Journal of Nursing Practice 2022; 28(3) doi: 10.1111/ijn.12946
120
Shraddha Jatwani, Bharat Malhotra, Teresa Crout, Vikas Majithia. Infections and the Rheumatic Diseases. 2019; : 399 doi: 10.1007/978-3-030-23311-2_37
121
Alexander M Oberc, Aline A Fiebig-Comyn, Caressa N Tsai, Wael Elhenawy, Brian K Coombes. Antibiotics Potentiate Adherent-InvasiveE. coliInfection and Expansion. Inflammatory Bowel Diseases 2019; 25(4): 711 doi: 10.1093/ibd/izy361
122
JRS Dandrieux, LM Martinez Lopez, N Prakash, CS Mansfield. Treatment response and long term follow up in nineteen dogs diagnosed with chronic enteropathy in Australia. Australian Veterinary Journal 2019; 97(9): 301 doi: 10.1111/avj.12846
123
Bárbara M. Schultz, Carolina A. Paduro, Geraldyne A. Salazar, Francisco J. Salazar-Echegarai, Valentina P. Sebastián, Claudia A. Riedel, Alexis M. Kalergis, Manuel Alvarez-Lobos, Susan M. Bueno. A Potential Role of Salmonella Infection in the Onset of Inflammatory Bowel Diseases. Frontiers in Immunology 2017; 8 doi: 10.3389/fimmu.2017.00191
124
Toshifumi Osaka, Eri Moriyama, Shunichi Arai, Yasuhiro Date, Junji Yagi, Jun Kikuchi, Satoshi Tsuneda. Meta-Analysis of Fecal Microbiota and Metabolites in Experimental Colitic Mice during the Inflammatory and Healing Phases. Nutrients 2017; 9(12): 1329 doi: 10.3390/nu9121329
125
叶卿 罗. Research Progress of Relapse Factors in Inflammatory Bowel Disease. Advances in Clinical Medicine 2022; 12(07): 6414 doi: 10.12677/ACM.2022.127924
126
Rachel E Andrew, Evangelos Messaris. Update on medical and surgical options for patients with acute severe ulcerative colitis: What is new?. World Journal of Gastrointestinal Surgery 2016; 8(9): 598-605 doi: 10.4240/wjgs.v8.i9.598
127
Kaiyuan Yu, Qiang Tang, Zhi Yao, Quan Wang. A mouse model to test the anti-inflammatory effect of facultative anaerobes on dextran sulfate sodium-induced colitis. STAR Protocols 2023; 4(1): 101988 doi: 10.1016/j.xpro.2022.101988
128
J. R. S. Dandrieux. Inflammatory bowel disease versus chronic enteropathy in dogs: are they one and the same?. Journal of Small Animal Practice 2016; 57(11): 589 doi: 10.1111/jsap.12588
129
Toumi Ryma, Arezki Samer, Imene Soufli, Hayet Rafa, Chafia Touil-Boukoffa. Role of Probiotics and Their Metabolites in Inflammatory Bowel Diseases (IBDs). Gastroenterology Insights 2021; 12(1): 56 doi: 10.3390/gastroent12010006
130
Siyu Li, Kan Xu, Yi Cheng, Lu Chen, Ailin Yi, Zhifeng Xiao, Xuefei Zhao, Minjia Chen, Yuting Tian, Wei Meng, Zongyuan Tang, Shuhong Zhou, Guangcong Ruan, Yanling Wei. The role of complex interactions between the intestinal flora and host in regulating intestinal homeostasis and inflammatory bowel disease. Frontiers in Microbiology 2023; 14 doi: 10.3389/fmicb.2023.1188455
131
Giovanni C Actis, Rinaldo Pellicano. Inflammatory bowel disease: Efficient remission maintenance is crucial for cost containment. World Journal of Gastrointestinal Pharmacology and Therapeutics 2017; 8(2): 114-119 doi: 10.4292/wjgpt.v8.i2.114
132
Shatakshi Sharma, Sunil Kumar, Sheeral Sajjad, Samriddhi Sharma. Probiotics in Irritable Bowel Syndrome: A Review Article. Cureus 2023;  doi: 10.7759/cureus.36565
133
Dong Wook Shin, Beong Ou Lim. Nutritional Interventions Using Functional Foods and Nutraceuticals to Improve Inflammatory Bowel Disease. Journal of Medicinal Food 2020; 23(11): 1136 doi: 10.1089/jmf.2020.4712
134
Jonathan D Schepper, Fraser Collins, Naiomy Deliz Rios‐Arce, Ho Jun Kang, Laura Schaefer, Joseph D Gardinier, Ruma Raghuvanshi, Robert A Quinn, Robert Britton, Narayanan Parameswaran, Laura R McCabe. Involvement of the Gut Microbiota and Barrier Function in Glucocorticoid‐Induced Osteoporosis. Journal of Bone and Mineral Research 2020; 35(4): 801 doi: 10.1002/jbmr.3947
135
Adeola Temitope Salami, Gloria Enevwo Okotie, Precious Nekachi Echendu, Uwaifoh Akpamu, Samuel Babafemi Olaleye. Potassium bromate (KBrO3) modulates oxidative stress and inflammatory biomarkers in sodium hydroxide (NaOH) – induced Crohn’s colitis in Wistar rats. Canadian Journal of Physiology and Pharmacology 2021; 99(10): 989 doi: 10.1139/cjpp-2020-0678
136
Xingyao Chen, Beatriz G. Mendes, Bruno Secchi Alves, Yi Duan. Phage Therapy - Part B. Progress in Molecular Biology and Translational Science 2023; 201: 93 doi: 10.1016/bs.pmbts.2023.04.005
137
Darren Fernandes, Jervoise Andreyev. The Role of the Human Gut Microbiome in Inflammatory Bowel Disease and Radiation Enteropathy. Microorganisms 2022; 10(8): 1613 doi: 10.3390/microorganisms10081613
138
Sebastian Gallo-Bernal, Alexis M. Cahalane, Michael S. Gee. Percutaneous Image-Guided Drainage of Abdominal Fluid Collections in Children: Technical Considerations and Clinical Scenarios. Digestive Disease Interventions 2023; 7(03): 187 doi: 10.1055/s-0042-1759547
139
Sabine Hazan, Neil Stollman, Huseyin S Bozkurt, Sonya Dave, Andreas J Papoutsis, Jordan Daniels, Brad D Barrows, Eamonn MM Quigley, Thomas J Borody. Lost microbes of COVID-19: Bifidobacterium, Faecalibacterium depletion and decreased microbiome diversity associated with SARS-CoV-2 infection severity. BMJ Open Gastroenterology 2022; 9(1): e000871 doi: 10.1136/bmjgast-2022-000871
140
Wei Du, Weili Han, Jiaqiang Dong. Long-term oral vancomycin for refractory inflammatory bowel diseases without Clostridium difficile infection: Lessons from primary sclerosing cholangitis. Medical Hypotheses 2020; 144: 110211 doi: 10.1016/j.mehy.2020.110211
141
Xiujing Zhang, Lizhuan Ma, Chao Zhang, Bingxu Hou, Yanli Zhou, Simiao Yu. Silencing LncRNA-DANCR attenuates inflammation and DSS-induced endothelial injury through miR-125b-5p. Gastroenterología y Hepatología (English Edition) 2021; 44(9): 644 doi: 10.1016/j.gastre.2021.09.004
142
Chuanfa Liu, Zhiming Li, Jiahong Ding, Hefu Zhen, Mingyan Fang, Chao Nie. Species-Level Analysis of the Human Gut Microbiome Shows Antibiotic Resistance Genes Associated With Colorectal Cancer. Frontiers in Microbiology 2021; 12 doi: 10.3389/fmicb.2021.765291
143
Yeyong Wang, Cheng Gao, Zhi Qu, Ming Li. The combined toxicity of binary mixtures of antibiotics against the cyanobacterium Microcystis is dose-dependent: insight from a theoretical nonlinear combined toxicity assessment method. Environmental Science and Pollution Research 2022; 29(8): 11612 doi: 10.1007/s11356-021-16594-4
144
Christy A Harrison, Daniel Laubitz, Monica T Midura-Kiela, Deepa R Jamwal, David G Besselsen, Fayez K Ghishan, Pawel R Kiela. Sexual Dimorphism in the Response to Broad-spectrum Antibiotics During T Cell-mediated Colitis. Journal of Crohn's and Colitis 2019; 13(1): 115 doi: 10.1093/ecco-jcc/jjy144
145
Peijie Zhong, Hang Wu, Yuanqiao Ma, Xiaoxiao Xu, Yizhuo Jiang, Chaolei Jin, Qiaozhen Zhu, Xinlei Liu, Zhimin Suo, Junpeng Wang. P2X4 receptor modulates gut inflammation and favours microbial homeostasis in colitis. Clinical and Translational Medicine 2023; 13(4) doi: 10.1002/ctm2.1227
146
Tommaso Venneri, Giada Giorgini, Nadine Leblanc, Nicolas Flamand, Francesca Borrelli, Cristoforo Silvestri, Vincenzo Di Marzo. Altered endocannabinoidome bioactive lipid levels accompany reduced DNBS-induced colonic inflammation in germ-free mice. Lipids in Health and Disease 2023; 22(1) doi: 10.1186/s12944-023-01823-1
147
J. Plaza-Diaz, F.J. Ruiz-Ojeda, M.J. Arias-Tellez, P. Solis-Urra, M.J. Saez-Lara, A. Gil. Microbiome and Metabolome in Diagnosis, Therapy, and other Strategic Applications. 2019; : 149 doi: 10.1016/B978-0-12-815249-2.00015-4
148
Zhenhuan Yang, Wenjing Liu, Xuefeng Zhou, Xiaoran Zhu, Feiya Suo, Shukun Yao. The effectiveness and safety of curcumin as a complementary therapy in inflammatory bowel disease. Medicine 2020; 99(43): e22916 doi: 10.1097/MD.0000000000022916
149
Yoshihiro Miyagi, Tatsuya Kinjo, Tomoharu Yoshizumi, Noboru Harada, Shingo Arakaki, Tetsu Kinjo, Akira Hokama, Mitsuhisa Takatsuki. Elective staged proctocolectomy and living donor liver transplantation for colon cancer with sclerosing cholangitis-related ulcerative colitis: a case report. Surgical Case Reports 2020; 6(1) doi: 10.1186/s40792-020-01059-6
150
Scott D. Lee, Anand Singla, Stephen J. Rulyak, Kindra Clark‐Snustad. Double‐blind, randomised, placebo‐controlled crossover trial to evaluate the clinical efficacy of rifaximin in patients with moderate to severe active Crohn’s disease. GastroHep 2020; 2(5): 185 doi: 10.1002/ygh2.416
151
Daniel A. Schupack, Ruben A. T. Mars, Dayne H. Voelker, Jithma P. Abeykoon, Purna C. Kashyap. The promise of the gut microbiome as part of individualized treatment strategies. Nature Reviews Gastroenterology & Hepatology 2022; 19(1): 7 doi: 10.1038/s41575-021-00499-1
152
Livia Moreira Genaro, Julian Furtado Silva, Luis Eduardo Miani Gomes, Hugo Dugolin Ceccato, Amanda Pereira Lima, Maria de Lourdes Setsuko Ayrizono, Marciane Milanski Ferreira, Raquel Franco Leal. Natural Plant Products in Inflammatory Bowel Diseases. 2023; : 47 doi: 10.1016/B978-0-323-99111-7.00013-1
153
Atsushi Kohyama, Kazuhiro Watanabe, Akira Sugita, Kitaro Futami, Hiroki Ikeuchi, Ken-ichi Takahashi, Yasuo Suzuki, Kouhei Fukushima. Ulcerative colitis-related severe enteritis: an infrequent but serious complication after colectomy. Journal of Gastroenterology 2021; 56(3): 240 doi: 10.1007/s00535-020-01742-3
154
Klára Szentmihályi, Szilvia Klébert, Zoltán May, Eszter Bódis, Miklós Mohai, László Trif, Tivadar Feczkó, Zoltán Károly. Immobilization of Metronidazole on Mesoporous Silica Materials. Pharmaceutics 2022; 14(11): 2332 doi: 10.3390/pharmaceutics14112332
155
Shuo Yuan, Ke-Si Wang, Huan Meng, Xiao-Ting Hou, Jia-Chen Xue, Bao-Hong Liu, Wen-Wen Cheng, Jiao Li, Hua-Min Zhang, Ji-Xing Nan, Qing-Gao Zhang. The gut microbes in inflammatory bowel disease: Future novel target option for pharmacotherapy. Biomedicine & Pharmacotherapy 2023; 165: 114893 doi: 10.1016/j.biopha.2023.114893
156
Shivani Yadav, Dhruvi Shah, Parmeswar Dalai, Reena Agrawal-Rajput. The tale of antibiotics beyond antimicrobials: Expanding horizons. Cytokine 2023; 169: 156285 doi: 10.1016/j.cyto.2023.156285
157
Omari Jones-Nelson, Andrey Tovchigrechko, Matthew S. Glover, Fiona Fernandes, Udaya Rangaswamy, Hui Liu, David E. Tabor, Jonathan Boyd, Paul Warrener, Jose Martinez, Jamese J. Hilliard, C. Ken Stover, Wen Yu, Gina DAngelo, Sonja Hess, Taylor S. Cohen, Bret R. Sellman. Antibacterial Monoclonal Antibodies Do Not Disrupt the Intestinal Microbiome or Its Function. Antimicrobial Agents and Chemotherapy 2020; 64(5) doi: 10.1128/AAC.02347-19
158
Nariman Hossein-Javaheri, Michael Youssef, Yaanu Jeyakumar, Vivian Huang, Parul Tandon. The Management of Inflammatory Bowel Disease during Reproductive Years: An Updated Narrative Review. Reproductive Medicine 2023; 4(3): 180 doi: 10.3390/reprodmed4030017
Write to the Help Desk
© 2004-2023 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

California Corporate Number: 3537345